Paris, France, April 24, 2012 – Nanobiotix, a company developing novel cancer nanotherapeutics, today announced it has appointed Dr. Bernd Muehlenweg, currently “Head of Business Development” as a member of the Executive Board in support of the future growth of Nanobiotix.
“Bernd’s expertise and experience with business development over the past twelve years and his involvement in the biotech and…